$1.76
0.09645.81%
Last update: Nov 4, 1:03 PM
Inovio Pharmaceuticals Inc
INONASDAQ
The average analyst price target for Inovio Pharmaceuticals is $14, 697.1% above the current price. Of 8 analysts, 7 rate it Buy and 1 Hold. Targets range from $3 to $40. The latest change came on Nov 2, 2026, when HC Wainwright & Co. upgraded Inovio Pharmaceuticals from Neutral to Buy with a $5 price target.
Price Target Range — 11 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
